|Using best–worst scaling to investigate preferences in health care|
KL Cheung, BFM Wijnen, IL Hollin, EM Janssen, JF Bridges, SMAA Evers, ...
Pharmacoeconomics 34, 1195-1209, 2016
|Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness|
EM Janssen, EE McGinty, ST Azrin, D Juliano-Bult, GL Daumit
General hospital psychiatry 37 (3), 199-222, 2015
|Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?|
EM Janssen, DA Marshall, AB Hauber, JFP Bridges
Expert review of pharmacoeconomics & outcomes research 17 (6), 531-542, 2017
|A framework for instrument development of a choice experiment: an application to type 2 diabetes|
EM Janssen, JB Segal, JFP Bridges
The Patient-Patient-Centered Outcomes Research 9, 465-479, 2016
|Assessing rationality in discrete choice experiments in health: an investigation into the use of dominance tests|
T Tervonen, T Schmidt-Ott, K Marsh, JFP Bridges, M Quaife, E Janssen
Value in Health 21 (10), 1192-1197, 2018
|Conducting a discrete-choice experiment study following recommendations for good research practices: an application for eliciting patient preferences for diabetes treatments|
EM Janssen, AB Hauber, JFP Bridges
Value in Health 21 (1), 59-68, 2018
|Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects|
EM Janssen, SM Dy, AS Meara, PJ Kneuertz, CJ Presley, JFP Bridges
Patient preference and adherence, 927-937, 2020
|Older adults’ preferences for discussing long-term life expectancy: results from a national survey|
NL Schoenborn, EM Janssen, C Boyd, JFP Bridges, AC Wolff, QL Xue, ...
The Annals of Family Medicine 16 (6), 530-537, 2018
|Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey|
J Mendivil, R Murphy, M de la Cruz, E Janssen, HB Boysen, G Jain, ...
Orphanet journal of rare diseases 16, 1-13, 2021
|Preferred clinician communication about stopping cancer screening among older US adults: results from a national survey|
NL Schoenborn, EM Janssen, CM Boyd, JFP Bridges, AC Wolff, ...
JAMA oncology 4 (8), 1126-1128, 2018
|The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management|
Y Jackson, E Janssen, R Fischer, K Beaverson, J Loftus, K Betteridge, ...
Expert Review of Pharmacoeconomics & Outcomes Research 19 (4), 383-396, 2019
|Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment|
EM Janssen, DR Longo, JK Bardsley, JFP Bridges
Patient preference and adherence, 1729-1736, 2017
|Caregiver treatment preferences for children with a new versus existing attention-deficit/hyperactivity disorder diagnosis|
S DosReis, A Park, X Ng, E Frosch, G Reeves, C Cunningham, ...
Journal of child and adolescent psychopharmacology 27 (3), 234-242, 2017
|Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy|
IL Hollin, H Peay, R Fischer, EM Janssen, JFP Bridges
Quality of Life Research 27, 2261-2273, 2018
|Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults|
NL Schoenborn, QL Xue, CE Pollack, EM Janssen, JFP Bridges, AC Wolff, ...
Preventive medicine reports 13, 244-248, 2019
|AcroVoice: eliciting the patients’ perspective on acromegaly disease activity|
Y Jackson, E Flood, S Rhoten, EM Janssen, M Lundie
Pituitary 22, 62-69, 2019
|Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach|
EM Janssen, HL Benz, JH Tsai, JFP Bridges
Expert review of medical devices 15 (5), 385-398, 2018
|Exploring variation in parental worries about HPV vaccination: a latent-class analysis|
MB Gilkey, D Mohan, EM Janssen, AL McRee, ML Kornides, JFP Bridges
Human Vaccines & Immunotherapeutics, 2019
|How do members of the Duchenne and Becker muscular dystrophy community perceive a discrete-choice experiment incorporating uncertain treatment benefit? An application of …|
JFP Bridges, JH Tsai, E Janssen, NL Crossnohere, R Fischer, H Peay
The Patient-Patient-Centered Outcomes Research 12, 247-257, 2019
|A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial|
EM Janssen, GJ Jerome, AT Dalcin, JV Gennusa III, S Goldsholl, KD Frick, ...
Obesity 25 (6), 1006-1013, 2017